130 related articles for article (PubMed ID: 6187181)
21. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer.
Findeisen R; Albrecht S; Richter B; Deutschmann K; Distler W
Clin Chem Lab Med; 1998 Nov; 36(11):841-6. PubMed ID: 9877089
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy and the expression of tissue-carcinoembryonic antigen in grade III carcinoma of the breast.
van Dam PA; Keersmaeckers G; Van Bockstaele DR; Uyttenbroeck FL
Eur J Obstet Gynecol Reprod Biol; 1991 Jan; 38(1):59-62. PubMed ID: 1846341
[TBL] [Abstract][Full Text] [Related]
23. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
24. [Value of CEA levels and of immunoscintigraphy (using CEA-marked antibodies) for the diagnosis and therapeutic monitoring of breast cancer: apropos of a case].
Doalto L; Paridaens R; Dodion P; Manil L; Rigo P; Fruhling J
Acta Clin Belg; 1991; 46(1):42-7. PubMed ID: 1645918
[TBL] [Abstract][Full Text] [Related]
25. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
26. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
[TBL] [Abstract][Full Text] [Related]
27. An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma.
Hitchcock A; Ellis IO; Robertson JF; Gilmour A; Bell J; Elston CW; Blamey RW
J Pathol; 1989 Oct; 159(2):129-34. PubMed ID: 2553906
[TBL] [Abstract][Full Text] [Related]
28. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
29. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
Sironi M; Cantaboni A
Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
[No Abstract] [Full Text] [Related]
30. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D
Am J Clin Oncol; 1996 Oct; 19(5):459-64. PubMed ID: 8823487
[TBL] [Abstract][Full Text] [Related]
31. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
[TBL] [Abstract][Full Text] [Related]
32. Detection of gastric cancer by a combination of tissue polypeptide antigen (TPA), lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA).
Uehara Y; Kojima O; Ikeda E; Majima T; Nishioka B; Fujita Y; Majima S
Gastroenterol Jpn; 1984 Oct; 19(5):424-9. PubMed ID: 6519414
[TBL] [Abstract][Full Text] [Related]
33. Carcino-embryonic antigen (CEA) in gastric adenocarcinomas. Morphologic patterns and their relationship to a histogenetic classification.
Nielsen K; Teglbjaerg PS
Acta Pathol Microbiol Immunol Scand A; 1982 Nov; 90(6):393-6. PubMed ID: 6187179
[TBL] [Abstract][Full Text] [Related]
34. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
[TBL] [Abstract][Full Text] [Related]
35. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen (CEA) in explants of human breast cancer: comparison of immunohistochemical detection and release during short-term culture.
Miller WR; Sturgeon CM; Walker RA
Br J Cancer; 1983 Mar; 47(3):429-32. PubMed ID: 6299320
[No Abstract] [Full Text] [Related]
37. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
38. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
[TBL] [Abstract][Full Text] [Related]
39. CEA, TPA and CA 15.3 in tissue and serum of breast cancer patients.
Saccani Jotti G; Grassi C; Fontanesi M; Becchi G; Gion M
Int J Biol Markers; 1992; 7(4):265-6. PubMed ID: 1491185
[No Abstract] [Full Text] [Related]
40. [CA 15-3 associated with CEA and TPA in the follow-up of breast carcinoma].
Maffei S; Rudoni M; Antonini G; Sacchetti G; Krengli M
Minerva Med; 1990 Nov; 81(11):759-63. PubMed ID: 2255409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]